Stay updated with breaking news from Impact Factor. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Abivax abstract on obefazimod phase 2b results selected for moderated poster presentation at UEG Week 2022Obefazimod (ABX464) interim 48-week safety and efficacy analysis from the ongoing phase 2b maintenance
Në faqet e portaleve shqiptare të disa ditëve më parë por kryesisht nga lajmet e Top Channel dolën disa konstatime nga dr
/PRNewswire/ -- Ascentage Pharma (6855.HK), a global biopharmaceutical company engaged in developing novel therapies for cancers, chronic hepatitis B (CHB),...
DGAP-News: ABIVAX / Key word(s): Half Year Results Abivax presents first-half 2022 financial results and operations update 15....
DGAP-News: ABIVAX / Key word(s): Half Year ResultsAbivax presents first-half 2022 financial results and operations update 15.09.2022 / 18:00 CET/CESTThe issuer is solely responsible for the content of this announcement.ABIVAX PRESENTS FIRST-HALF 2022 FINANCIAL RESULTS AND OPERATIONS UPDATE Obefazimod global piv...